(Q48156013)

9 February 2018

title

ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression. (English)

1 reference

9 February 2018

author

Laura C. Lazzeroni

7

1 reference

9 February 2018

author name string

A Ray

1

1 reference

9 February 2018

L Tennakoon

2

1 reference

9 February 2018

J Keller

3

1 reference

9 February 2018

J E Sarginson

4

1 reference

9 February 2018

H S Ryan

5

1 reference

9 February 2018

G M Murphy

6

1 reference

9 February 2018

M H Trivedi

8

1 reference

9 February 2018

J H Kocsis

9

1 reference

9 February 2018

C DeBattista

10

1 reference

9 February 2018

A F Schatzberg

11

1 reference

9 February 2018

publication date

9 December 2014

1 reference

9 February 2018

The Pharmacogenomics Journal

published in

1 reference

9 February 2018

volume

15

1 reference

9 February 2018

issue

4

1 reference

9 February 2018

page(s)

332-339

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/tpj.2014.72

exact match

0 references

cites work

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Association between genetic variation in the ABCB1 gene and switching, discontinuation, and dosage of antidepressant therapy: results from the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

MDR1 in paroxetine-induced sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Report by the ACNP Task Force on response and remission in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Effects of sertraline and fluoxetine on p-glycoprotein at barrier sites: in vivo and in vitro approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

dbSNP: the NCBI database of genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FTPJ.2014.72

21 January 2018

12 December 2020

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response

1 reference

12 December 2020

ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.

1 reference

12 December 2020

In vitro P-glycoprotein efflux ratio can predict the in vivo brain penetration regardless of biopharmaceutics drug disposition classification system class

1 reference

12 December 2020

The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study

1 reference

12 December 2020

ABCB1 (P-glycoprotein/MDR1) gene G2677T/a sequence variation (polymorphism): lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline

1 reference

12 December 2020

REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.

1 reference

12 December 2020

Single nucleotide polymorphism in the drug transporter gene ABCB1 in treatment-resistant depression: clinical practice

1 reference

12 December 2020

Identifiers

DOI

10.1038/TPJ.2014.72

1 reference

9 February 2018

PubMed ID

25487678

1 reference

9 February 2018